A functional association between merlin and HEI10, a cell cycle regulator

被引:25
作者
Gronholm, M.
Muranen, T.
Toby, G. G.
Utermark, T.
Hanemann, C. O.
Golemis, E. A.
Carpen, O.
机构
[1] Univ Helsinki, Program Neurosci, Biomed Helsinki, Dept Pathol, Helsinki 00014, Finland
[2] Helsinki Univ Hosp, Helsinki 00014, Finland
[3] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA USA
[4] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany
[5] Peninsula Med Sch, Clin Neurobiol, Inst Clin & Biomed Sci, Plymouth, Devon, England
[6] Turku Univ, Dept Pathol, Turku, Finland
[7] Turku Univ Hosp, FIN-20520 Turku, Finland
关键词
NF2; ERM; HEI10;
D O I
10.1038/sj.onc.1209475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Merlin and ezrin are homologous proteins with opposite effects on neoplastic growth. Merlin is a tumor suppressor inactivated in the neurofibromatosis 2 disease, whereas upregulated ezrin expression is associated with increased malignancy. Merlin's tumor suppressor mechanism is not known, although participation in cell cycle regulation has been suggested. To characterize merlin's biological activities, we screened for molecules that would interact with merlin but not ezrin. We identified the cyclin B-binding protein and cell cycle regulator HEI10 as a novel merlin-binding partner. The interaction is mediated by the alpha-helical domain in merlin and the coiled-coil domain in HEI10 and requires conformational opening of merlin. The two proteins show partial subcellular colocalization, which depends on cell cycle stage and cell adhesion. Comparison of Schwann cells and schwannoma cultures demonstrated that the distribution of HEI10 depends on merlin expression. In transfected cells, a constitutively open merlin construct affected HEI10 protein integrity. These results link merlin to the cell cycle control machinery and may help to understand its tumor suppressor function.
引用
收藏
页码:4389 / 4398
页数:10
相关论文
共 39 条
[1]   Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization [J].
Alfthan, K ;
Heiska, L ;
Grönholm, M ;
Renkema, GH ;
Carpen, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (18) :18559-18566
[2]   ALTERNATIVE SPLICING OF THE NF2 GENE AND ITS MUTATION ANALYSIS OF BREAST AND COLORECTAL CANCERS [J].
ARAKAWA, H ;
HAYASHI, N ;
NAGASE, H ;
OGAWA, M ;
NAKAMURA, Y .
HUMAN MOLECULAR GENETICS, 1994, 3 (04) :565-568
[3]   ERM proteins and merlin: Integrators at the cell cortex [J].
Bretscher, A ;
Edwards, K ;
Fehon, RG .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (08) :586-599
[4]   Coiled coils: a highly versatile protein folding motif [J].
Burkhard, P ;
Stetefeld, J ;
Strelkov, SV .
TRENDS IN CELL BIOLOGY, 2001, 11 (02) :82-88
[5]   Ezrin mutants affecting dimerization and activation [J].
Chambers, DN ;
Bretscher, A .
BIOCHEMISTRY, 2005, 44 (10) :3926-3932
[6]  
DENBAKKER MA, 1995, AM J PATHOL, V147, P1339
[7]   Regulation of tumor suppressors by nuclear-cytoplasmic shuttling [J].
Fabbro, M ;
Henderson, BR .
EXPERIMENTAL CELL RESEARCH, 2003, 282 (02) :59-69
[8]   Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas [J].
Geiger, KD ;
Stoldt, P ;
Schlote, W ;
Derouiche, A .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (06) :1785-1793
[9]   Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF [J].
Gonzalez-Agosti, C ;
Wiederhold, T ;
Herndon, ME ;
Gusella, J ;
Ramesh, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34438-34442
[10]  
GonzalezAgosti C, 1996, ONCOGENE, V13, P1239